HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Celiac disease markers in patients with liver diseases: a single center large scale screening study.

AbstractAIM:
To study the coincidence of celiac disease, we tested its serological markers in patients with various liver diseases.
METHODS:
Large-scale screening of serum antibodies against tissue transglutaminase (tTG), and deamidated gliadin using enzyme-linked immunosorbent assay and serum antibodies against endomysium using immunohistochemistry, in patients with various liver diseases (n = 962) and patients who underwent liver transplantation (OLTx, n = 523) was performed. The expression of tTG in liver tissue samples of patients simultaneously suffering from celiac disease and from various liver diseases using immunohistochemistry was carried out. The final diagnosis of celiac disease was confirmed by histological analysis of small-intestinal biopsy.
RESULTS:
We found that 29 of 962 patients (3%) with liver diseases and 5 of 523 patients (0.8%) who underwent OLTx were seropositive for IgA and IgG anti-tTG antibodies. However, celiac disease was biopsy-diagnosed in 16 patients: 4 with autoimmune hepatitis type I, 3 with Wilson's disease, 3 with celiac hepatitis, 2 with primary sclerosing cholangitis, 1 with primary biliary cirrhosis, 1 with Budd-Chiari syndrome, 1 with toxic hepatitis, and 1 with non-alcoholic steatohepatitis. Unexpectedly, the highest prevalence of celiac disease was found in patients with Wilson's disease (9.7%), with which it is only rarely associated. On the other hand, no OLTx patients were diagnosed with celiac disease in our study. A pilot study of the expression of tTG in liver tissue using immunohistochemistry documented the overexpression of this molecule in endothelial cells and periportal hepatocytes of patients simultaneously suffering from celiac disease and toxic hepatitis, primary sclerosing cholangitis or autoimmune hepatitis type I.
CONCLUSION:
We suggest that screening for celiac disease may be beneficial not only in patients with associated liver diseases, but also in patients with Wilson's disease.
AuthorsPavel Drastich, Eva Honsová, Alena Lodererová, Marcela Jarešová, Aneta Pekáriková, Iva Hoffmanová, Ludmila Tučková, Helena Tlaskalová-Hogenová, Julius Spičák, Daniel Sánchez
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 18 Issue 43 Pg. 6255-62 (Nov 21 2012) ISSN: 2219-2840 [Electronic] United States
PMID23180946 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Immunoglobulin A
  • Immunoglobulin G
  • Gliadin
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • GTP-Binding Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Autoantibodies (blood)
  • Biopsy
  • Celiac Disease (blood, diagnosis, epidemiology, immunology)
  • Czech Republic (epidemiology)
  • Female
  • GTP-Binding Proteins
  • Gliadin (immunology)
  • Humans
  • Immunoglobulin A (blood)
  • Immunoglobulin G (blood)
  • Immunohistochemistry
  • Liver (enzymology)
  • Liver Diseases (diagnosis, epidemiology, surgery)
  • Liver Transplantation
  • Male
  • Mass Screening (methods)
  • Middle Aged
  • Predictive Value of Tests
  • Prevalence
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases (immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: